Abstract Artemisinin is a potent antimalarial drug; however, it suffers from unstable and insufficient supply from plant source. Here, we established a novel multivariate-modular approach based on experimental design for systematic pathway optimization that succeeded in improving the production of amorphadiene (AD), the precursor of artemisinin, in Escherichia coli. It was initially found that the AD production was limited by the imbalance of glyceraldehyde 3-phosphate (GAP) and pyruvate (PYR), the two precursors of the 1-deoxy-D-xylulose-5-phosphate (DXP) pathway. Furthermore, it was identified that GAP and PYR could be balanced by replacing the phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS) with the ATP-dependent galactose permease and glucose kinase system (GGS) and this resulted in fivefold increase in AD titer (11 to 60 mg/L). Subsequently, the experimental design-aided systematic pathway optimization (EDASPO) method was applied to systematically optimize the transcriptional expressions of eight critical genes in the glucose uptake and the DXP and AD synthesis pathways.
Introduction
In Escherichia coli and other bacteria, isoprenoids are synthesized through the 1-deoxy-D-xylulose-5-phosphate (DXP) pathway originating from two precursors (pyruvate (PYR) and glyceraldehyde 3-phosphate (GAP)). As equal amounts of two precursors are optimal for the DXP pathway, the imbalance of the two precursors could reduce the biosynthesis of isoprenoids. The conversion from G3P to pyruvate involves three reversible enzymatic steps and one essentially irreversible step (between phosphoenolpyruvate (PEP) and PYR, Fig. 1 ) (Farmer and Liao 2001) . And it was reported that redirection of metabolic flux from PYR to PEP by the overexpression of the gluconeogenic enzyme, PEP synthetase (ppsA), enhanced lycopene yield (Farmer and Liao 2000; Farmer and Liao 2001) . The results indicate that it is possible to balance the G3P and PYR through the manipulation of the ratio between PEP and PYR, and redirection of metabolic flux from PYR to GAP is beneficial for isoprenoid production. Similarly, inactivation of the carbohydrate phosphotransferase system (PTS) can also increase the ratio between PEP and PYR (Chatterjee et al. 2001; Flores et al. 1996; Zhang et al. 2009b) , thus is potentially applicable to enhance isoprenoid biosynthesis in E. coli.
The phosphotransferase system (PTS) is composed of enzyme I (EI), histidine protein (HPr), sugar-specific enzyme IIA (EIIA), and enzyme IICB (EIICB), encoded by gene ptsHIcrr operon and ptsG, respectively. The PTS is the major glucose uptake pathway in E. coli, and half of the PEP produced from glucose is metabolized into PYR during the glucose uptake by the PTS (Gorke and Stulke 2008) . Thus, the deletion of the PTS can increase the intracellular PEP/PYR ratio and thus increase the intracellular GAP/PYR ratio. However, the disruption of the PTS resulted in the decreased glucose uptake rate and significantly impeded cell growth (Martínez et al. 2008) . To address this issue, adaptive evolution was used to select fast-growing strains (Flores et al. 1996) . Transcriptome analysis in these fast-growing strains indicated that the expressions of gene galP (coding for galactose permease), glk (coding for glucose kinase), and pgi (coding for phosphoglucose isomerase) were increased as compared to the wild-type strain, suggesting that these genes were important in enhancing glucose uptake Flores et al. 2002) . Hence, it was reported that the overexpression of galP and glk enhanced the growth rate of microbes in glucose medium Lu et al. 2012 ) and improved the yields of valuable products such as aromatics (Yi et al. 2003) , recombinant protein (De Anda et al. 2006) , and ethanol (Hernandez-Montalvo et al. 2003) . Combinatorial modulation of galP and glk gene expressions has been used to improve cell growth rate (Lu et al. 2012 ), but it is unclear if such an approach will increase the production of isoprenoids. Global control and balance of metabolic pathways for AD production. T7, TM1, TM2, and TM3 promoters were used to fine control the expression of the four different modules (galP-glk, dxs, ispDF-idi or idi, and ispA-ADS). The metabolites in the figure were as follows: glucose (GLC), glucose-6-phosphate (G6P), glyceraldehyde 3-phosphate (GAP), phosphoenolpyruvate (PEP), pyruvate (PYR), 1-deoxy-D-xylulose 5-phosphate (DXP), 2C-methyl-D-erythritol 4-phosphate (MEP), 4-diphosphocytidyl-2C-methyl-D-erythritol (CDPME), 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate (CDPMEP), 2C-methyl-D-erythritol 2,4-diphosphate (MEC), hydroxylmethylbutenyl diphosphate (HMBPP), isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), geranyl diphosphate (GPP), farnesyl pyrophosphate (FPP), and amorpha-4,11-diene (AD). The enzyme-coding genes in the figure were as follows: PTS enzyme IIBC (ptsG), histidine protein (ptsH), PTS enzyme I (ptsI), PTS enzyme IIA(crr), galactose permease (galP), glucose kinase (glk), phosphoenolpyruvate synthetase (ppsA), DXP synthase (dxs), DXP reductase (dxr), CDPME synthase (ispD), CDPME kinase (ispE), CDPMEP synthase (ispF), HMBPP synthase (ispG), HMBPP reductase (ispH), IPP isomerase (idi), FPP synthase (ispA), and AD synthase (ADS) Pathway optimization by modulating the activities and expressions of enzymes in the pathway is critical for improving product yields. Optimized pathways can minimize the accumulation of intermediate metabolites with potential cytotoxicity and thus decrease the metabolic burdens and increase the final product titers Pfleger et al. 2006) . Multivariate-modular approach to balance metabolic pathway has been successfully used to systematically search for the optimal conditions for taxadiene production, resulting in 15, 000-fold increase in taxadiene titer over the control (Ajikumar et al. 2010) . Modulating plasmid copy numbers or engineering different types of promoters (Jones et al. 2000) has been used to control and balance the expression levels of multiple genes for more than 10 years. However, these approaches are time consuming and resource demanding and may not cover a sufficiently broad search space to allow the identification of conditions for optimal productivity.
In this study, the hypothesis that amorphadiene (AD) production from glucose can be improved by enhancing the availability of GAP through PEP was tested. By deleting the PTS and overexpressing the ATP-dependent galactose permease and glucose kinase system (GGS), the AD production was significantly increased by fivefold. Optimization of the production of AD was then carried out by experimental design-aided systematic pathway optimization (EDASPO) to globally regulate four distinct modules (including eight critical genes in the glucose uptake and the DXP and AD synthesis pathways) with small number of experiments. Using T7 promoter variants with different transcriptional efficiencies to control multiple modules simultaneously (Too et al. 2014) , EDASPO method enables the rapid discovery of the optimal conditions for high productivity with a small number of experiments. Based on the relative transcriptional efficiencies of T7 promoter and its variants, regression analysis of the fourmodule data predicted the optimal expression ranges for each module to further increase AD production. And the prediction was validated experimentally, resulting in another threefold enhancement in AD titer.
Materials and methods

Bacterium strains and plasmids
E. coli K12 MG1655 ΔrecAΔendA DE3 was used as the parental strain (Ajikumar et al. 2010 ). MG1655 ΔPTS::FRT (PTS-for short) strain was obtained by replacing operon ptsHIcrr with a kanamycin-resistant gene using the λ Red recombination system . And the kanamycin-resistant gene was subsequently excised by the Flp/FRT site-specific recombination system (Datsenko 2000) . Chromosomal deletions were verified by testing for antibiotic markers and colony PCR analysis.
Plasmid pET-galP-glk was constructed from three parts, pETaa vector, gene galP, and gene glk, by cross-lapping in vitro assembly (CLIVA) method using I-pETR(galPF), I-galPF(pETR), I-galPR(glkF), IglkF(galPR), I-pETF(glkR), and I-glkR(pETF) ( Table 1) . Plasmids pETA-TM1/2/3-galP-glk were constructed from pET-galP-glk by mutating T7 promoter to TM1/TM2/TM3 promoter using the oligo TM1, TM2, and TM3 (Table 1) . Plasmid p15A-spec-T7-ppsA was constructed from two parts, 15A-spec vector and ppsA gene, by CLIVA method using IppsA(t7pr)-F, I-ppsA(t7tf)-R, I-T7P(-)-R, and I-T7T(-)-F ( Table 1 ).
All the information about the strains, plasmids, and primers is in Tables 1 and 2 .
Construction of the four-module expression system
The four modules were controlled simultaneously under T7 and T7 variant promoters with different transcriptional efficiencies (TM1, TM2, and TM3; the transcriptional efficiencies of TM1, TM2, and TM3 were 92, 37, and 16 % of that of T7 promoter, respectively). TM1, TM2, and TM3 promoters were generated as described in the patent (Table 1) (Too et al. 2014) . A portion of combinations was chosen based on the principles of experimental design and a priori knowledge about three-module (dxs, ispDF-idi, ispA-ADS) optimization results. In the three-module experiments, the construct 231 (where the three modules dxs, ispDF-idi, and ispA-ADS were controlled by TM2, TM3, and TM1 promoters, respectively) and the construct 332 (where the three modules dxs, ispDF-idi, and ispA-ADS were controlled by TM3, TM3, and TM2 promoters, respectively) produced the highest titers of AD and thus were included in this experiment. To cover a broad range, each module was controlled by three different promoters (TM1, TM2, and TM3). Each promoter for each module was repeated at least three times (for example, TM1 for the first module was used in four constructs, P1231, P1332, P1121, and P1313). As a result, 14 construct were chosen and tested with four different concentrations of isopropyl β-D-1-thiogalactopyranoside (IPTG) ( Table 3 ).
Media and culture conditions
Defined media composition
The defined media without carbon contained 4 g/L (NH 4 ) 2 HPO 4 , 3.50 g/L KH 2 PO 4 and 9.28 g/L K 2 HPO 4 , (Cunningham et al. 1994 ) by replacing crtEBI with ppsA under the control of T7 promoter and replacing chloramphenicol-resistant gene with spectinomycin-resistant gene
This study pETA-galP-glk pET-11a (Novagen) derived, galP-glk operon under the control of T7 promoter
This study pETA-TM1-galP-glk pETA-galP-glk derived by mutating T7 promoter to TM1 promoter This study pETA-TM2-galP-glk pETA-galP-glk derived by mutating T7 promoter to TM2 promoter This study pETA-TM3-galP-glk pETA-galP-glk derived by mutating T7 promoter to TM3 promoter This study pBAD-galP-glk pBAD-B (Invitrogen) derived, galP-glk operon was placed under the control araBAD promoter
This study pACM-T7-dxs-T7-idi-T7-ADS-ispA pAC-LYC derived, dxs-idi-ADS-ispA operon was placed under the control of T7 promoter
This study pACM-T7-dxs-idi-ispDF-T7-ADS-ispA pAC-LYC derived, dxs-idi-ispDF-ADS-ispA operon was placed under the control of T7 promoter
This study pETK-lacI pET-11a derived, ampicillin-resistant gene was replaced with kanamycinresistant gene using CLIVA This study pACM-TM2-dxs-TM3-idi-ispDF-TM1-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the control of TM2, TM3, and TM1 promoters, respectively (Too et al. 2014) pACM-TM3-dxs-TM3-idi-ispDF-TM2-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the control of TM3, TM3, and TM2 promoters, respectively (Too et al. 2014) pACM-TM1-dxs-TM2-idi-ispDF-TM1-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the control of TM1, TM2, and TM1 promoters, respectively (Too et al. 2014) pACM-TM1-dxs-TM1-idi-ispDF-TM1-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the control of TM1, TM1, and TM1 promoters, respectively (Too et al. 2014) pACM-TM3-dxs-TM1-idi-ispDF-TM3-ADS pAC-LYC derived, dxs, idi-ispDF, and ADS were placed under the control of TM3, TM1, and TM3 promoters, respectively The asterisked oligos were phosphorothioate-modified oligos used for CLIVA cloning All the amorpha-4,11-diene titers reported here were based on the strains grown in the defined media supplemented with 20 g/L glucose.
2xpy medium composition
The 2xpy medium contained 20 g/L peptone, 10 g/L yeast extract, and 10 g/L NaCl. The medium was adjusted to pH 7.0 and autoclaved at 121°C for 20 min.
Culture conditions
New transformed strains were rescued and grown in 2xpy medium overnight, and 1 % (v/v) overnight grown cell culture was inoculated into 1 mL defined media in a 14-mL BD Falcon™ tube. Dodecane with 100 mg/L beta-caryophyllene was added to 20 % (v/v) of the medium volume. Cells were grown at 28°C with 300 rpm shaking speed and induced with different dosages of IPTG when OD 600 reached the range of 0.5~1.0. The media were supplemented with 100 mg/L ampicillin, 34 mg/L chloramphenicol, 50 mg/L kanamycin, and 100 mg/L spectinomycin to maintain the pET-11a-derived plasmids, pAC-LYC-derived plasmids, pETKlacI, and p15A-spec-T7-ppsA, respectively. AD quantification AD was extracted by diluting 5 μL dodecane phase into 495 μL ethyl acetate and analyzed on an Agilent 7980A gas chromatograph equipped with an Agilent 5975C mass spectrometer (GC/MS). Beta-caryophyllene (Sigma-Aldrich) was used as an equivalent, and the GC-MS condition was set as the method reported by scanning for only two ions (204 and 189 m/z ion) (Tsuruta et al. 2009 ).
Calculation of relative expression of each module
Relative expression level of each module was calculated based on the promoter transcriptional efficiencies and plasmid copy numbers. It is calculated using the following equation.
where E i is the relative expression level of the module i in the construct C, M i is the promoter transcriptional efficiency of module i, and N i is the plasmid copy number of module i. For example, the transcriptional efficiencies of TM1, TM2, and TM3 were 92, 37, and 16 % of that of T7 promoter, pETA-TM1-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA P1000 This study MG1655 DE3 ΔPTS::FRT pETA-TM2-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA P2000 This study MG1655 DE3 ΔPTS::FRT pETA-TM3-galP-glk and pACM-T7-dxs-T7-idi-ADS-ispA P3000 This study respectively; the first module was in the pAC-derived vector (p15a origin) with around ten copies, and the other three modules were in the pET-derived vector (pBR322 origin) with about 30 copies. Therefore, the relative expression level of the first module (galP-glk) in strain P1231 was
Results
Overexpression of ppsA increased AD production
In this study, the native DXP pathway in E. coli was used to produce AD (Fig. 1) . The DXP pathway starts from PYR to GAP. PYR is abundant inside the cells and known to be exported out of the cells (Kreth et al. 2013) , and the redirection of metabolic flux from PYR to GAP by the overexpression of PEP synthetase (ppsA) has been shown to enhance lycopene yield (Farmer and Liao 2000) . To test the hypothesis that the overexpression of ppsA can similarly enhance the production of another isoprenoid, AD, cells were transformed with a plasmid encoding the endogenous ppsA gene under the control of the T7 promoter. As high expression of ppsA is toxic and negatively affects the growth of E. coli (Farmer and Liao 2000; Patnaik et al. 1992 ), the expression of ppsA was moderately induced at levels that did not significantly affect cell growth (Fig. 2b) . As shown in Fig. 2 , the AD titer (mg/L) and specific yield (mg/L/OD) increased to about twofold when ppsA was overexpressed in all the conditions examined (different concentrations of IPTG). The result was consistent with the hypothesis that increasing the availability of GAP through increasing the intracellular PEP (Fig. 1) would increase AD production, albeit modestly.
Overexpression of galP and glk increased AD production Similar to the ppsA overexpression, the PTS knockout can also increase the intracellular PEP. As glucose uptake via the PTS is known to consume half of PEP produced from glucose and produces PYR (Hernandez-Montalvo et al. 2003) , an attempt was made to use an alternative pathway for the cells to import glucose. Unlike the PTS which uses PEP as phosphate donor, the GGS transports and phosphorylates glucose using ATP as phosphate donor, thus increasing intracellular PEP and increasing the availability of intracellular GAP. As shown in Fig. 3 , overexpression of the GGS in the wild type using T7 promoter (The resulting strain was named as MGG, Table 2 ) resulted in an increase in AD titer (mg/L) by more than threefold (from 10 to 37 mg/L) as compared to wild type (MGG01, Table 2 ). With the PTS deletion and the overexpression of the GGS, AD titer (The resulting strain was named as PGG, Table 2 ) was further increased by 70 % to~60 mg/L as compared to that of MGG. The specific yield of AD increased from about 7 mg/L/OD (MGG) to~12 mg/L/OD (PGG). The results indicated that the glucose uptake pathway played a significant part in the AD production where the ATP-dependent GGS (PGG strain, Table 2 ) was superior to the PEP-dependent PTS (MGG01 strain, Table 2 ). Noteworthy, the cell density was similar for the three strains in most of the conditions except that the cell density of MGG and PGG was very low when high concentration of inducer was used. This suggested that the high expression of the GGS could be toxic to cells.
Differential control of multivariant modules encoding critical enzymes in the glucose uptake and the DXP and AD synthesis pathways
A two-module optimization of the upstream DXP pathway and heterologous downstream terpenoid-forming pathway increased Taxol precursor titer significantly (Ajikumar et al. 2010) . As the replacement of the PTS with the GGS increased AD yield, we hypothesized that the global pathway optimization of the GGS and the DXP and AD synthesis pathways could further increase AD production. It was reported that overexpression of dxs, ispDF, and idi improved the yields of carotenoids (Alper et al. 2005; Yuan et al. 2006 ) and taxol precursor (Ajikumar et al. 2010 ). In addition, ADS has been identified as a critical step for the AD production Pitera et al. 2007 ). All these important enzymes and glucose uptake transporters were grouped into four modules. The first module encoded galP-glk, which regulates glucose uptake. The second module encoded dxs, which diverts the carbon flux from central metabolic pathway into the DXP pathway. The operon ispDF-idi was encoded in the third module where ispDF facilitates the conversion of intermediates of the DXP pathway and idi is crucial for balancing the ratio of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Lastly, ispA and ADS genes were encoded in the fourth module where enzyme ispA condensates IPP and DMAPP into FPP and FPP is cyclized into AD by enzyme ADS (Fig. 1) . All the four modules were controlled simultaneously under the native T7 promoter or its variants (TM1, TM2, and TM3) in a combinatorial manner. As a result, the total combination of four-module system with four different promoters has 4 4 = 256 constructs. To limit the number of conditions to be tested, 14 constructs (Fig. 4d) were analyzed based on the experimental design principle (the details about these constructs were explained in BMaterials and methods^). As shown in Fig. 4 , through the differential control of the four modules, AD titer varied significantly by more than 190-fold from 0.36 mg/L (strain P1313 with 0.03 mM IPTG) to 68.9 mg/L (strain P2121 with 0.01 mM IPTG).
Regression analysis of the four-module expression system
To identify the global optimal condition and to gain an insight into the behavior of the four-module expression system, a linear regression model was used to analyze the experimental data in Fig. 4 . The relative expression of each module (Table 3) was calculated from the transcriptional efficiencies of promoters and copy numbers of plasmids, as described in BMaterials and methods^. As the relative expression of each module is independent of the inducer dosage, the averages of AD titers at different inducer dosages were used in the regression analysis. The experimental data and regression model were shown in three-dimensional figures for each two modules (Fig. S1 ). For the ease of visualization and analyses, the data were also demonstrated as two-dimensional heat maps for each two modules using a linear regression model (Fig. 5) . Based on the analyses, the optimal ranges for the four modules were well accounted by the 14 chosen constructs. The predicted optimal ranges of relative expression levels of the four modules (galP-glk, dxs, ispDF-idi, and ispA-ADS) were 0.04~0.1, 0.25~0.4, 0.1~0.4, and 0.25~0.44, respectively. Thus, a relatively lower expression of the first module (galP-glk) was found to be beneficial for AD production. Higher expression levels of the second (dxs) and the fourth modules (ispA-ADS) were required. Interestingly, for the third module (ispDF-idi), both low expression (~0.15) and high expression (~0.35) resulted in higher AD production. Especially in Fig. 5b , there were two optimal ranges for the third module (ispDF-idi) when the relative expression level of the first module (galP-glk) is within 0.04~0.1. Further studies demonstrated the operon ispDF in the third module was less important and may even be adverse for AD production in certain conditions (Fig. S2 ).
Further improvement of AD production facilitated by regression analysis
From the regression analysis of four-module expression system data, we concluded that the first module encoding galPglk was beneficial when expressed at a relatively lower level; modules encoding dxs and ispA-ADS were required to be expressed at relatively higher levels, and the expression of ispDF in third module was unnecessary. Thus, we constructed strains where the genes dxs, idi, and the operon ispA-ADS were under the control of the native T7 promoter, and the operon galP-glk was controlled by TM1, TM2, or TM3 promoter (Fig. 1 , the details of the three strains were shown in Table 2 ). The relative expression levels of the four modules for the three strains were shown in Table 4 . As a result, the highest AD titer in strain P2000 increased by~3-fold when compared to that of P2121, an increase from 68.9 to 201.2 mg/L (Fig. 6 ). In addition, the specific yield was also enhanced significantly from~12.2 to~18.0 mg/L/OD, validating the prediction from regression analysis. Interestingly, similar to other 14 strains of the four-module expression systems, the cell density of strain P1000, P2000, and P3000 was inversely correlated with the inducer dosages (Fig. 6b) .
Discussion
In E. coli, isoprenoid biosynthesis is reported to be limited by imbalance of GAP and PYR, or specifically, the GAP is less abundant than the PYR. As PEP and GAP are interconvertible with three reversible enzymatic reactions, the overexpression of ppsA (catalyzing PYR to PEP) or pck (converting oxaloacetate to PEP) can increase the availability of intracellular GAP by increasing intracellular PEP and thus enhanced the production of lycopene (a C40 isoprenoid) (Farmer and Liao 2000; Farmer and Liao 2001) . Similarly, the AD production was a The strains were named based on their sequence of promoters; numbers B1,^B2,^and B3^stood for TM1, TM2, and TM3 promoters, respectively (e.g., P1231 referred to a construct in which galP-glk, dxs, idi, and ispA-ADS were controlled by TM1, TM2, TM3, and TM1 promoters, respectively) OD optical density of culture at 600 nm. MGG01 strain was the control strain without overexpressing ppsA, whereas ppsA was overexpressed in MGG02 strain Fig. 3 The effect of different glucose uptake pathways (the GGS and/or the PTS) on AD production. MGG01 was the wild-type strain which used the PTS to import glucose. MGG was the wild-type strain with the GGS overexpressed which used both the PTS and the GGS to import the glucose, and PGG was the PTS knockout mutant with the GGS overexpressed; thus, the glucose was imported solely by the GGS predictably increased when ppsA was overexpressed, indicative of the importance of balancing GAP and PYR (Fig. 2) . This inspired us to explore the productivity of the PTS knockout strain, as inactivating the PTS can increase intracellular PEP and thus may increase intracellular GAP. Thus, it was hypothesized that the deletion of the PTS could potentially redirect more carbon flux from the central pathway to the synthesis of isoprenoids through the DXP pathway. In E. coli, the PTS is the main glucose transport system and is also responsible for carbon catabolite repression (CCR) and chemotaxis (Hernandez-Montalvo et al. 2003) . Thus, deletion of the PTS is also pleiotropic and its mutant has several distinct characteristics over the wild-type strain, such as enhancement of intracellular PEP concentration, coexistence of glycolytic and gluconeogenic pathways, and the simultaneous utilization of different carbon sources (Flores et al. 2002) . The PTS mutant is able to co-utilize xylose and glucose (Nichols et al. 2001 ) and produces higher titers of various compounds such as recombinant proteins (Chou et al. 1994) , aromatics (Flores et al. 1996) , lysine (Lindner et al. 2011 ), L-phenylalanine (Baez-Viveros et al. 2007 , and succinate (Zhang et al. 2009b) . However, the uptake rate of glucose in PTS mutant is known to be low Flores et al. 2002) and consequently the growth rate is exceptionally low. Therefore, in this study, the GGS was overexpressed in the PTS-deficient mutant in an attempt to increase the biomass when grown on glucose.
As predicted, the use of the GGS (consuming ATP) to increase glucose uptake in the PTS-deficient mutant was found to be beneficial for AD production (Fig. 3) . Considering the benefit of using the GGS glucose uptake pathway, we hypothesized that global pathway balancing of the glucose uptake and the DXP and AD synthesis pathways may further improve the AD production. Although AD titer varied more than 190-fold within different conditions, the best construct (P2121) only improved AD titer by 15 % than that of Fig. 4 Optimization of AD production by simultaneously controlling four modules. TM1, TM2, and TM3 promoters were used to control the expression of the four modules: galP-glk, dxs, ispDF-idi, and ispA-ADS. The strains were named based on their sequence of promoters, and numbers 1, 2, and 3 stood for TM1, TM2, and TM3 promoters, respectively, e.g., P1231 referred to a construct in which the four modules galP-glk, dxs, ispDF-idi and ispA-ADS were under the control of TM1, TM2, TM3, and TM1 promoters, respectively. The transcriptional efficiencies of TM1, TM2, and TM3 were 92, 37, and 16 % of that of T7 promoter, respectively. a AD titer (mg/L). b Cell density of different strains. c Specific yield of AD (mg/L/DO). d Illustration of different constructs (the thickness of arrows represented the relative transcriptional efficiencies of promoters) PGG strain. And it was also observed that high expressions of the GGS improved specific yield of AD but inhibited cell growth in PGG and MGG (Fig. 3) and the 14 strains of the four-module expression system (Fig. 4) . The decreased cell density at high induction level is likely to be due to the stress of high expression of galactose permease and glucose kinase (Lu et al. 2012) or sugar phosphate stress due to accumulation of glucose-6-phosphate or fructose-6-phosphate (Morita et al. 2003) , and this requires further investigation. Nevertheless, this limitation can be mitigated with tight control of the expressions of galP and glk using the combinatorial modular expression system described herein.
To better understand the behavior of the four-module expression system, the experimental data were analyzed using a linear regression model. Based on the regression analysis (Fig. 5) , the optimal ranges of expression levels for the first, second, and fourth modules were identified using the panel of constructs. However, the third module was predicted to have multiple optimal ranges (~0.15 and~0.35). Further experiment indicated that excluding ispDF resulted in a slightly enhanced AD production as compared to the inclusion of ispDF in our conditions (Fig. S2) . This finding was consistent with previous reports that enhancement in production of various metabolites requires only dxs and idi but not ispDF to be overexpressed or modulated (Jin and Stephanopoulos 2007; Morrone et al. 2010; Sun et al. 2014) and that the overexpression of ispDF operon even decreased isoprenoid production . The enzymes ispD and ispF were reported to be more soluble than the enzymes dxs and idi and may have higher activities (Zhou et al. 2012) ; hence, the overexpression of ispDF may be unnecessary when the pathway was optimized, and further study is required to address this issue. The fourth module was required to be expressed at higher levels as the activity of heterologous ADS from Artemisia annua is known to be poor in E. coli Green et al. 2009 ). Consistent with the prediction of the a The strains were named based on their sequence of promoters; number B0,^B1,^B2,^and B3^stood for T7, TM1, TM2, and TM3 promoters, respectively (e.g., P1000 referred to a construct in which galP-glk, dxs, idi, and ispA-ADS were controlled by TM1, T7, T7, and T7 promoters, respectively) regression model, the combination of a relatively lower expression of galP-glk and higher expression of dxs and ispA-ADS enhanced AD production. These predictions were validated experimentally using strains P1000, P2000, and P3000 where AD titer increased another threefold as compared to the highest titer in the 14 constructs (overall~19-fold increase over that of wild type). To our knowledge, this was the first study that simultaneously controlled four expression modules. These results demonstrated the successful application of EDASPO for the pathway optimization, especially when more than three modules were involved. And the major advantage of EDASPO lies in its predictability with a small portion of the full combination; thus, it significantly decreases the time cost and the work amount. In this study, a chemically defined medium (CDM), instead of complex media (CM), was used to produce AD. It was worth noting that the 20 g/L glucose added into the CDM was more than enough (other nutrition was limiting), and there was glucose left in the media (data not shown) when the AD was harvested for all the experiments. In most cases, CDM has a relatively low production unless through extensive medium optimization. However, CDM has a few advantages. For example, CDM is more cost-effective as CM ingredients (such as yeast extract, tryptone, and peptone) are much more expensive than inorganic nitrogen salts (such as ammonium salts or ammonia). Furthermore, unlike CM whose composition varies with batches and suppliers, CDM is more reliable and scalable, making it a preferred medium for fed-batch high-cell density cultivations . In addition, the complicated interactions among complex components in CM may interfere with the pathway optimization and kinetic study, thus making data more difficult to interpret (Zhang et al. 2009a) . It is interesting to note that the AD yield (18 mg/L/OD) using the DXP pathway was among some of the highest yields reported to date Zhou et al. 2013) . However, as compared to the highest AD yield using the mevalonate (MVA) pathway in Saccharomyces cerevisiae (242 mg/L/ OD) (Westfall et al. 2012) , our yield was~13-fold lower. Preliminary study of optimizing the MVA pathway using EDASPO resulted in a comparable AD yield of more than 200 mg/L/OD in E. coli (unpublished observation), demonstrating the broader utility of this approach. Fig. 6 Further improvement of AD production facilitated by regression analysis. a AD titer (mg/L). b Cell density of different strains. c Specific yield of AD (mg/L/DO). In strains P1000, P2000, and P3000, the galP-glk was placed under the control of TM1, TM2, and TM3 promoters, respectively. And all the other genes were placed under the control of T7 promoter. The strains were named based on their sequence of promoters, and numbers 0, 1, 2, and 3 stood for T7, TM1, TM2, and TM3 promoters, respectively, e.g., P1000 referred to a construct in which galP-glk, dxs, idi, and ispA-ADS were controlled by TM1, T7, T7, and T7 promoters, respectively
